Daily non-political popular news in brief.

Women may be able to 'take break' from osteoporosis drug without losing benefit

Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.

Read more »

Keywords: women, able, break, osteoporosis, drug, losing, benefit, osteoporosi

« Previous | Next »

Similar news on "Women may be able to 'take break' from osteoporosis drug without losing benefit":

1. Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment
   09-18-2007 · EurekAlert!
   Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.Researchers evaluated 87 women enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study.
   Similar news · Read more »
   
2. Less Is More (Bone): Yearly osteoporosis drug reduces fractures
   05-05-2007 · Science News Online
   Older women with osteoporosis who received yearly infusions of a drug that prevents bone loss had far fewer fractures than did peers who didn't get the drug.
   Similar news · Read more »
   
3. Men more likely to benefit from clot-busting stroke treatment
   03-12-2007 · EurekAlert!
   Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
4. Women on osteoporosis drug can discontinue use with no risk
   12-26-2006 · EurekAlert!
   A long-term study of the most widely used osteoporosis drug has found that many women can discontinue the drug after five years without increasing their fracture risk for as long as five more years.
   Similar news · Read more »
   
5. Dietary supplement boosts IVF hopes
   10-24-2007 · EurekAlert!
   A number of women undergoing IVF are self-medicating with a supplement called dehydroepiandrosterone to improve the chances of using their own eggs to conceive with IVF instead of using a donor. Results from small preliminary trials report that doctors were able to harvest more ripe eggs from those women taking DHEA. Exactly how it boosts egg maturation is unclear, and some experts warn that it is too early to tell whether DHEA offers a genuine benefit.
   Similar news · Read more »
   
6. Some women benefit more from exercise when emphasis is on health, not appearance
   08-09-2007 · EurekAlert!
   A new study suggests that women with chronic issues with their body-image are more likely to benefit from an exercise class where the instructor emphasizes the health benefits of the workout over improved appearance, even if those women chose the class in hopes of improving their physique. Researchers studied nearly 100 college-aged women who had social physique anxiety -- a disorder in which someone chronically worries that others are critiquing his or her body.
   Similar news · Read more »
   
7. Study finds drug spending caps cause some seniors to quit taking key medicines
   09-11-2007 · EurekAlert!
   Many seniors quit taking drugs for chronic illnesses such as diabetes and high blood pressure when they exceed their drug plan's yearly spending limits, according to a RAND Corp. study. The report, which examines the behavior of seniors enrolled in a private health plan, provides insight into how seniors may act under provisions of Medicare's new drug benefit plan that will leave about one-third of enrollees without drug coverage for some part of each benefit year.
   Similar news · Read more »
   
8. When to have a child? A new approach to the decision
   11-07-2007 · EurekAlert!
   Women seeking to balance career, social life and family life in making the decision on when to have a child may benefit from applying formal decision-making science to this complex emotional choice.
   Similar news · Read more »
   
9. Study urges compensation-based approach to drug patent compulsory licensing
   07-10-2007 · EurekAlert!
   A Penn State researcher argues that ambiguous international rules outlining when and how governments may "break" pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.
   Similar news · Read more »
   
10. New data reveal pregnancies exposed to accutane despite risk management program
    07-31-2007 · EurekAlert!
    More than 120 pregnancies were exposed during the first year of iPledge, a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), a report revealed. The Food and Drug Administration's Dermatologic and Ophthalmic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee will discuss the report's findings Aug. 1
    Similar news · Read more »